78.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Abortion Drugs Market Deep Research and Growth in Future Scope - openPR.com
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT) - FinancialContent
Deutsche Bank AG Buys 24,051 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
CORT Q1 Earnings Call: Pharmacy Disruptions Overshadow Prescription Growth, Guidance Reaffirmed - Yahoo Finance
Critical Review: Kaya (OTCMKTS:KAYS) vs. Corcept Therapeutics (NASDAQ:CORT) - Defense World
Cushing's Disease Market Poised for Significant Growth Across the 7MM During the Study Period (2020-2034) with Rising Awareness and Diagnostic Improvements | DelveInsight - Yahoo Finance
Cushing's Syndrome Market Growth Drivers and Industry Insights - openPR.com
Corcept Therapeutics (NASDAQ:CORT) Downgraded to “Hold” Rating by StockNews.com - Defense World
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years - Benzinga
Corcept Therapeutics (NASDAQ:CORT) Is Posting Promising Earnings But The Good News Doesn’t Stop There - Yahoo Finance
Why Corcept Therapeutics (CORT) Is Among the Best Performing Healthcare Stocks to Buy Now - Insider Monkey
11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey
Investor Network: Corcept Therapeutics Incorporated. to Host Earnings Call - ACCESS Newswire
HC Wainwright Has Pessimistic Outlook of CORT Q2 Earnings - Defense World
Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Price Target at $143.25 - Defense World
Corcept Therapeutics chief development officer sells $524,652 in stock By Investing.com - Investing.com India
Corcept Therapeutics chief development officer sells $524,652 in stock - Investing.com Australia
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus
High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
HC Wainwright Has Lowered Expectations for Corcept Therapeutics (NASDAQ:CORT) Stock Price - Defense World
Corcept Therapeutics (NASDAQ:CORT) Raised to Buy at StockNews.com - Defense World
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript - Insider Monkey
CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall - MSN
Corcept Therapeutics price target lowered to $135 from $150 at Truist - Yahoo Finance
Corcept Therapeutics (NASDAQ:CORT) Shares Gap Down on Insider Selling - Defense World
Corcept Therapeutics (NasdaqCM:CORT) Reports US$21M Q1 Net Income Lowers EPS - Yahoo Finance
Corcept Therapeutics (CORT) Faces Price Target Cut Amid Revenue Concerns | CORT Stock News - GuruFocus
Assessing Corcept Therapeutics: Insights From 9 Financial Analysts - Benzinga
Truist Cuts Price Target on Corcept Therapeutics to $135 From $150, Keeps Buy Rating - marketscreener.com
H.C. Wainwright cuts Corcept Therapeutics target to $145 By Investing.com - Investing.com Nigeria
Corcept Therapeutics (CORT) Receives Revised Price Target from A - GuruFocus
Corcept Therapeutics (CORT) Receives Revised Price Target from Analyst | CORT Stock News - GuruFocus
Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Pr - GuruFocus
Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Price Target | CORT Stock News - GuruFocus
Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Es - GuruFocus
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS A - GuruFocus
Corcept Therapeutics (CORT) Pre-Earnings Options Activity Sugges - GuruFocus
Corcept Therapeutics Inc (CORT) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges - GuruFocus
Decoding Corcept Therapeutics Inc (CORT): A Strategic SWOT Insig - GuruFocus
Corcept Therapeutics Reports Q1 2025 Financial Results - TipRanks
Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars - MSN
Corcept: Q1 Earnings Snapshot - MySA
Corcept Therapeutics (CORT) Anticipates Future Growth Amid Reven - GuruFocus
Corcept Therapeutics (CORT) Set to Announce Q1 Earnings - GuruFocus
Earnings call transcript: Corcept Therapeutics Q1 2025 earnings beat expectations By Investing.com - Investing.com UK
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates - Yahoo Finance
Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops - Yahoo Finance
Corcept Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CORCEPT THERAPEUTICS Earnings Results: $CORT Reports Quarterly Earnings - Nasdaq
Corcept Therapeutics Q1 Earnings Decrease, Revenue Rises -- Shares Fall After Hours - marketscreener.com
Corcept Therapeutics (CORT) Reports Q1 Revenue Miss | CORT Stock News - GuruFocus
Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Estimates, Revenue of $157.2M Misses Expectations - GuruFocus
Corcept Therapeutics misses revenue estimates, stock falls By Investing.com - Investing.com UK
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE | CORT Stock News - GuruFocus
Corcept Earnings: $157M Revenue and Breakthrough ALS Survival Data Spark Pipeline Momentum - Stock Titan
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Bluefield Daily Telegraph
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):